Danaher Corporation (DHR)
NYSE: DHR · IEX Real-Time Price · USD
245.80
-4.61 (-1.84%)
At close: Apr 25, 2024, 4:00 PM
244.99
-0.81 (-0.33%)
Pre-market: Apr 26, 2024, 8:48 AM EDT
Danaher Market Cap
Danaher has a market cap or net worth of $182.06 billion as of April 26, 2024. Its market cap has decreased by -2.44% in one year.
Market Cap
182.06B
Enterprise Value
193.19B
1-Year Change
-2.44%
Ranking
Category
Stock Price
$245.80
Market Cap Chart
Since December 1, 1998, Danaher's market cap has increased from $6.13B to $182.06B, an increase of 2,872.23%. That is a compound annual growth rate of 14.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2024 | 185.48B | -1.07% |
| Apr 23, 2024 | 187.48B | 7.36% |
| Apr 22, 2024 | 174.63B | 0.24% |
| Apr 19, 2024 | 174.21B | -0.36% |
| Apr 18, 2024 | 174.84B | -1.27% |
| Apr 17, 2024 | 177.08B | -0.40% |
| Apr 16, 2024 | 177.78B | 0.28% |
| Apr 15, 2024 | 177.28B | -0.12% |
| Apr 12, 2024 | 177.49B | -1.66% |
| Apr 11, 2024 | 180.49B | -0.76% |
| Apr 10, 2024 | 181.87B | -1.57% |
| Apr 9, 2024 | 184.78B | 2.27% |
| Apr 8, 2024 | 180.67B | -0.01% |
| Apr 5, 2024 | 180.69B | 0.98% |
| Apr 4, 2024 | 178.93B | -1.00% |
| Apr 3, 2024 | 180.74B | -0.65% |
| Apr 2, 2024 | 181.92B | -0.75% |
| Apr 1, 2024 | 183.29B | -0.77% |
| Mar 28, 2024 | 184.72B | 0.38% |
| Mar 27, 2024 | 184.02B | 0.12% |
| Mar 26, 2024 | 183.79B | 0.27% |
| Mar 25, 2024 | 183.30B | -2.75% |
| Mar 22, 2024 | 188.48B | 0.27% |
| Mar 21, 2024 | 187.97B | 0.97% |
| Mar 20, 2024 | 186.17B | -0.81% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck & Co. | 321.34B |
| AbbVie | 300.20B |
| AstraZeneca | 219.62B |
| Thermo Fisher | 219.33B |
| Novartis AG | 190.33B |
| Abbott Laboratories | 186.69B |
| Pfizer | 148.62B |
| Amgen | 146.60B |